ImmunoPET may be useful in quantitatively assessing antigen targeting by antibody-based therapies, allowing for noninvasive interrogation of all sites of disease over time. In these images of patients with clear cell renal cancer, antigen distribution is heterogeneous within the primary tumor but relatively homogeneous within metastatic nodes.
See page 535.